The recent clinical research published in the ‘Diabetes Care’ journal has disclosed that the novel artificial pancreas system is now able to adjust and monitor the glucose levels in patients with a small to no annoyance with the help of smartphone. Unlike the previous AP systems, this latest iteration that consist of receiver for continuous monitoring the glucose in body, an insulin pump and a smartphone connected to Bluetooth.
The new update in the AP system uses the algorithmic calculations based on clouds to identify the adaptations to insulin delivery weekly without appointing assistance from clinicians or users. The efforts of researchers for developing an adaptive algorithm are depend on their previous strategy, which is named as ‘model-predictive control’.
The system can manage the variations as well as basal control by making a target to reach up to the acceptable range of glucose level in the body and to build an algorithm for improving the redundant daily cycles.
A team of researchers followed 30 adult participant patients suffering from type 1 diabetes to test the new iteration of automated pancreas system. After the study of 12 weeks, the team observed levels of the hemoglobin A1c (HbA1c) in participated patients, which is a better indicator of diabetics blood sugar, along with the secondary records generated by the constant glucose monitoring system.
A dean and professor, Frank Doyle from the School of Engineering and Applied Sciences of Harvard, stated that, “This is by far the longest duration trial we have conducted, and it is a testament to the robustness of the algorithm that our key performance indices were maintained from our earlier, shorter trials. Moreover, we took a disciplined group that had very good overall HbA1c levels before the trial, and we brought the group level even lower.”